Evidence map›Paper›PMID 25697518›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2015

The rhodopsin-arrestin-1 interaction in bicelles.

Qiuyan Chen, Sergey A Vishnivetskiy, Tiandi Zhuang, Min-Kyu Cho, Tarjani M Thaker, Charles R Sanders, Vsevolod V Gurevich, T M Iverson

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiuyan ChenDepartment of Pharmacology, Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN, 37232-6600, USA.
Sergey A Vishnivetskiy
Tiandi Zhuang
Min-Kyu Cho
Tarjani M Thaker
Charles R Sanders
Vsevolod V Gurevich
T M Iverson

Funding

STRUCTURE/FUNCTION STUDIES OF VISUAL ARRESTINR01EY011500 · NEI · VANDERBILT UNIVERSITY · PI T M Iverson · 1997 to 2026
$12.3M
Molecular basis for arrestin-mediated signalingR01GM120569 · NIGMS · VANDERBILT UNIVERSITY · PI T M Iverson · 2016 to 2026
$1.9M
Stabilization of Membrane Protein Signaling ComplexesR01GM095633 · NIGMS · VANDERBILT UNIVERSITY · PI IVERSON, T M · 2010 to 2013
$1.2M
NEI NIH HHS R01 EY011500NIGMS NIH HHS R01 GM095633NIGMS NIH HHS R01 GM120569
6 · The paper itself

Abstract

G-protein-coupled receptors (GPCRs) are essential mediators of information transfer in eukaryotic cells. Interactions between GPCRs and their binding partners modulate the signaling process. For example, the interaction between GPCR and cognate G protein initiates the signal, while the interaction with cognate arrestin terminates G-protein-mediated signaling. In visual signal transduction, arrestin-1 selectively binds to the phosphorylated light-activated GPCR rhodopsin to terminate rhodopsin signaling. Under physiological conditions, the rhodopsin-arrestin-1 interaction occurs in highly specialized disk membrane in which rhodopsin resides. This membrane is replaced with mimetics when working with purified proteins. While detergents are commonly used as membrane mimetics, most detergents denature arrestin-1, preventing biochemical studies of this interaction. In contrast, bicelles provide a suitable alternative medium. An advantage of bicelles is that they contain lipids, which have been shown to be necessary for normal rhodopsin-arrestin-1 interaction. Here we describe how to reconstitute rhodopsin into bicelles, and how bicelle properties affect the rhodopsin-arrestin-1 interaction.

Indexed as

ArrestinModels, BiologicalPhosphorylationReceptors, G-Protein-CoupledRhodopsinSignal TransductionArrestinReceptors, G-Protein-CoupledRhodopsin

Identifiers

PMID25697518
PMCPMC4520306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.